Literature DB >> 22837870

Silent gastroesophageal reflux disease.

Ching-Liang Lu1.   

Abstract

Entities:  

Year:  2012        PMID: 22837870      PMCID: PMC3400810          DOI: 10.5056/jnm.2012.18.3.236

Source DB:  PubMed          Journal:  J Neurogastroenterol Motil        ISSN: 2093-0879            Impact factor:   4.924


× No keyword cloud information.
Gastroesophageal reflux disease (GERD) is defined as the presence of acid-reflux-related symptoms, or esophageal mucosal damage, caused by the reflux of gastric contents into the esophagus.1 The diagnosis of GERD can therefore be easily made by patients' complaint of typical (heartburn and regurgitation) and/or atypical acid-reflux-related symptoms (chest pain, globus, chronic cough and asthma etc). On the other hand, the GERD diagnosis can also be obtained through esophagogastroduodenoscopy (EGD) by visible esophageal mucosal break. Recently, non-erosive gastroesophageal reflux disease (NERD) has been defined as the presence of acid-reflux-related symptoms, but without esophageal mucosal breaks.2 Symptomatic GERD is costly, brings a significant negative impact on health-related quality of life, and even is linked with esophageal adenocarcinoma.3-5 GERD had been considered as an uncommon disease in Asia. However, in recent years, a rising prevalence of both GERD and reflux esophagitis has been reported in various Asian countries. Most of the GERD cases reported in Asia are of the non-erosive type, and complications such as Barrett's esophagus and esophageal adenocarcinoma still rare in this part of the world.6,7 Fass and Dickman8 has first described the concept of so called 'silent GERD,' which referred to the presence of esophageal mucosal injury (ie, erosion, ulceration or even Barrett's esophagus) visible in EGD, but without typical or atypical GERD symptoms. Actually, a population-based study from Sweden already showed that up to 36.8% of patients with erosive esophagitis had no symptoms in 2004.9 Several studies from Asia by investigating the subjects receiving routine EGD check-up have described the characteristics of the silent GERD.10-15 These Asian studies showed the prevalence of the silent GERD ranged from 11.6% to 45.3% in patients with EGD-proven erosive esophagitis. Factors leading to asymptomatic esophagitis have been evaluated in these studies and with inconsistent results. For example, both Nozu and Wang identified male sex as a predictive factor for silent GERD.11,12 Cho et al13 found older age (> 60 years old) and male sex were predictive of asymptomatic esophagitis. Smoking and lower body mass index (BMI) were shown to be the predictive factors for silent GERD in a Japan study,11 while Wang from Taiwan found that a higher BMI predicted absence of symptoms in erosive esophagitis.12 In another survey from Taiwan, neither age nor BMI was associated with asymptomatic GERD.14 But, male sex, hiatus hernia and positivity for Helicobacter pylori infection were predictive of silent GERD. A recent study from Japan showed the patients with asymptomatic esophagitis were older and had more frequent use of calcium channel blockers than the symptomatic ones. In this issue, Lee et al15 from Korea conducted a small scaled study by enrolling 29 symptomatic and 26 asymptomatic patients with erosive gastritis from routine check-up. The demographic data, atypical GERD symptoms, dyspeptic symptoms and psychological symptoms were compared between the symptomatic and silent GERD patients. Not surprisingly, the authors found that symptomatic GERD patients were more likely to have atypical symptoms, functional dyspepsia symptoms and higher scores on psychological symptoms (somatization, obsessive-compulsiveness and phobic anxiety) than those without. These findings were consistent with the study from Japan showing quality of life was more impaired in symptomatic than asymptomatic patients with reflux esophagitis.14 The authors then concluded that psychological status and associated dyspeptic or atypical symptoms should be assessed in GERD patients, especially in refractory cases.15 We fully agreed with the author's suggestion. Actually, the association between psychological factor and GERD symptoms has already been well documented. For example, GERD patients who are chronically anxious and exposed to prolonged stress tend to perceive low intensity esophageal stimuli as painful reflux symptoms.16 Beside the psychological issue frequently associated with GERD patients, the unanswered, but still important, question is the clinical implication and long-term prognosis in these silent GERD patients. Whether the treatment is necessary in this group of GERD 'patient' is an open question. To further characterized the natural history of silent esophagitis may be required for resolving this issue. While the majority of the silent GERD patients are of milder form of esophagitis (grade A or B), whether they will evolve into more severe grades (C or D) and even Barrett's esophagus if left untreated is unclear. Even though Barrett's and esophageal adenocarcinoma are still rare in Asian countries,6 the data from Western countries suggested that around 25% of Barrett's esophagus and 40% of all esophageal adenocarcinomas occurred in patients without, or with only minimal, prior reflux symptoms.5,17 Thus, these patients with silent erosive esophagitis may need to be regularly followed up. Furthermore, patients with refractory asthma and chronic cough are sometimes associated with GERD but without typical GERD symptoms.18,19 For these patients, the presence of acid reflux may partially contribute to the refractory respiratory symptoms. Proton-pump inhibitors may be initiated in this group of patients. In conclusion, the risk factors and natural history for silent GERD remain unclear. More studies are needed to better characterize and give proper suggestions to this group of 'patients'.
  19 in total

1.  Social and medical impact, sleep quality and the pharmaceutical costs of heartburn in Taiwan.

Authors:  C-L Lu; H-C Lang; F-Y Chang; T-J Chen; C-Y Chen; J-C Luo; S-D Lee
Journal:  Aliment Pharmacol Ther       Date:  2005-10-15       Impact factor: 8.171

2.  Clinical characteristics of asymptomatic esophagitis.

Authors:  Tsukasa Nozu; Hiroaki Komiyama
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

3.  Silent acid reflux and asthma control.

Authors:  Koichiro Asano; Hidekazu Suzuki
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

4.  Erosive esophagitis in asymptomatic subjects: risk factors.

Authors:  Fu-Wei Wang; Ming-Shium Tu; Hung-Yi Chuang; Hsien-Chung Yu; Lung-Chih Cheng; Ping-I Hsu
Journal:  Dig Dis Sci       Date:  2009-08-14       Impact factor: 3.199

Review 5.  Nonerosive reflux disease--current concepts and dilemmas.

Authors:  R Fass; M B Fennerty; N Vakil
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

6.  High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report.

Authors:  Jukka Ronkainen; Pertti Aro; Tom Storskrubb; Sven-Erik Johansson; Tore Lind; Elisabeth Bolling-Sternevald; Hans Graffner; Michael Vieth; Manfred Stolte; Lars Engstrand; Nicholas J Talley; Lars Agréus
Journal:  Scand J Gastroenterol       Date:  2005-03       Impact factor: 2.423

7.  The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Authors:  Nimish Vakil; Sander V van Zanten; Peter Kahrilas; John Dent; Roger Jones
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

8.  Improved diagnosis of gastro-oesophageal reflux in patients with unexplained chronic cough.

Authors:  K Blondeau; L J Dupont; V Mertens; J Tack; D Sifrim
Journal:  Aliment Pharmacol Ther       Date:  2007-03-15       Impact factor: 8.171

9.  Prevalence of Barrett's esophagus in asymptomatic individuals.

Authors:  Lauren B Gerson; Katerina Shetler; George Triadafilopoulos
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

10.  The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors.

Authors:  L A Bradley; J E Richter; T J Pulliam; J M Haile; I C Scarinci; C A Schan; C B Dalton; A N Salley
Journal:  Am J Gastroenterol       Date:  1993-01       Impact factor: 10.864

View more
  5 in total

1.  Prevalence and Predictors of Silent Gastroesophageal Reflux Disease in Patients with Hypertension.

Authors:  He Suyu; Yijun Liu; Xu Jianyu; Guiquan Luo; Lipeng Cao; Xiaoqi Long
Journal:  Gastroenterol Res Pract       Date:  2018-04-23       Impact factor: 2.260

2.  Management of Asymptomatic Erosive Esophagitis: An E-Mail Survey of Physician's Opinions.

Authors:  Seong Woo Lim; Jun Haeng Lee; Jie-Hyun Kim; Jeong Hwan Kim; Heung Up Kim; Seong Woo Jeon
Journal:  Gut Liver       Date:  2013-04-09       Impact factor: 4.519

Review 3.  Highlights from the 52nd Seminar of the Korean Society of Gastrointestinal Endoscopy.

Authors:  Eun Young Kim; Il Ju Choi; Kwang An Kwon; Ji Kon Ryu; Ki Baik Hahm
Journal:  Clin Endosc       Date:  2015-07-24

4.  Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective.

Authors:  Yen-Wen Wu; Ping-Huei Tseng; Yi-Chia Lee; Shan-Ying Wang; Han-Mo Chiu; Chia-Hung Tu; Hsiu-Po Wang; Jaw-Town Lin; Ming-Shiang Wu; Wei-Shiung Yang
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

5.  Comparing the Effect of Psyllium Seed on Gastroesophageal Reflux Disease With Oral Omeprazole in Patients With Functional Constipation.

Authors:  Mousalreza Hosseini; Roshanak Salari; Mina Akbari Rad; Maryam Salehi; Batul Birjandi; Masoumeh Salari
Journal:  J Evid Based Integr Med       Date:  2018 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.